IMUX
Price
$1.34
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
9 days until earnings call
VERV
Price
$5.94
Change
-$0.00 (-0.00%)
Updated
Oct 28 closing price
7 days until earnings call
Ad is loading...

IMUX vs VERV

Header iconIMUX vs VERV Comparison
Open Charts IMUX vs VERVBanner chart's image
Immunic
Price$1.34
Change-$0.00 (-0.00%)
Volume$891.41K
CapitalizationN/A
Verve Therapeutics
Price$5.94
Change-$0.00 (-0.00%)
Volume$1.34M
CapitalizationN/A
View a ticker or compare two or three
IMUX vs VERV Comparison Chart
Loading...
IMUX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
IMUX vs. VERV commentary
Oct 30, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUX is a Buy and VERV is a StrongBuy.

COMPARISON
Comparison
Oct 30, 2024
Stock price -- (IMUX: $1.35 vs. VERV: $5.94)
Brand notoriety: IMUX and VERV are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUX: 116% vs. VERV: 104%
Market capitalization -- IMUX: $148.63M vs. VERV: $409.16M
IMUX [@Biotechnology] is valued at $148.63M. VERV’s [@Biotechnology] market capitalization is $409.16M. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.92B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUX’s FA Score shows that 0 FA rating(s) are green whileVERV’s FA Score has 1 green FA rating(s).

  • IMUX’s FA Score: 0 green, 5 red.
  • VERV’s FA Score: 1 green, 4 red.
According to our system of comparison, both IMUX and VERV are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUX’s TA Score shows that 3 TA indicator(s) are bullish while VERV’s TA Score has 5 bullish TA indicator(s).

  • IMUX’s TA Score: 3 bullish, 6 bearish.
  • VERV’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, VERV is a better buy in the short-term than IMUX.

Price Growth

IMUX (@Biotechnology) experienced а -12.90% price change this week, while VERV (@Biotechnology) price change was +7.03% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.91%. For the same industry, the average monthly price growth was +2.47%, and the average quarterly price growth was -6.27%.

Reported Earning Dates

IMUX is expected to report earnings on Feb 20, 2025.

VERV is expected to report earnings on Feb 26, 2025.

Industries' Descriptions

@Biotechnology (+0.91% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERV($409M) has a higher market cap than IMUX($149M). IMUX YTD gains are higher at: -10.000 vs. VERV (-57.389). IMUX has higher annual earnings (EBITDA): -93.53M vs. VERV (-215.68M). VERV has more cash in the bank: 576M vs. IMUX (79.7M). IMUX has less debt than VERV: IMUX (955K) vs VERV (72.5M). VERV has higher revenues than IMUX: VERV (20.6M) vs IMUX (0).
IMUXVERVIMUX / VERV
Capitalization149M409M36%
EBITDA-93.53M-215.68M43%
Gain YTD-10.000-57.38917%
P/E RatioN/AN/A-
Revenue020.6M-
Total Cash79.7M576M14%
Total Debt955K72.5M1%
FUNDAMENTALS RATINGS
IMUX: Fundamental Ratings
IMUX
OUTLOOK RATING
1..100
3
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
55
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMUXVERV
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
88%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
78%
Advances
ODDS (%)
Bullish Trend 13 days ago
85%
Bullish Trend 5 days ago
86%
Declines
ODDS (%)
Bearish Trend 20 days ago
85%
Bearish Trend 22 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
View a ticker or compare two or three
Ad is loading...
IMUX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VERV
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME22.732.16
+10.50%
GameStop Corp
BTC.X69907.7600001978.460900
+2.91%
Bitcoin cryptocurrency
AAPL233.401.99
+0.86%
Apple
SPY580.831.79
+0.31%
SPDR® S&P 500® ETF Trust
TSLA262.51-6.68
-2.48%
Tesla

IMUX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMUX has been loosely correlated with NTLA. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if IMUX jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUX
1D Price
Change %
IMUX100%
-2.88%
NTLA - IMUX
41%
Loosely correlated
+2.45%
RVMD - IMUX
40%
Loosely correlated
+2.87%
DNA - IMUX
40%
Loosely correlated
+1.35%
ALEC - IMUX
39%
Loosely correlated
+6.91%
PGEN - IMUX
38%
Loosely correlated
-0.61%
More

VERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERV has been loosely correlated with BEAM. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if VERV jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERV
1D Price
Change %
VERV100%
-0.50%
BEAM - VERV
57%
Loosely correlated
+3.71%
PGEN - VERV
52%
Loosely correlated
-0.61%
CRSP - VERV
49%
Loosely correlated
+4.96%
NTLA - VERV
49%
Loosely correlated
+2.45%
EDIT - VERV
49%
Loosely correlated
+2.52%
More